Theravance Biopharma Inc (NASDAQ:TBPH)

23.93
Delayed Data
As of 4:00pm ET
 +0.19 / +0.80%
Today’s Change
21.27
Today|||52-Week Range
43.44
-14.20%
Year-to-Date

Today’s Trading

Previous close23.74
Today’s open23.62
Day’s range23.15 - 23.98
Volume147,133
Average volume (3 months)247,955
Market cap$1.4B
Data as of 4:00pm ET, 06/18/2018

Growth & Valuation

Earnings growth (last year)-27.93%
Earnings growth (this year)+13.15%
Earnings growth (next 5 years)+8.07%
Revenue growth (last year)-68.37%
P/E ratioNM
Price/Sales94.90
Price/Book12.05

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...-2.50-12.90%
CBMCambrex Corp-0.10-0.21%
ARRYArray Biopharma Inc-0.43-2.40%
RGENRepligen Corp+0.18+0.40%
Data as of 4:02pm ET, 06/18/2018

Financials

Next reporting dateAugust 14, 2018
EPS forecast (this quarter)-$1.20
Annual revenue (last year)$15.4M
Annual profit (last year)-$285.4M
Net profit margin-1,854.97%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Rick E. Winningham
Chief Financial Officer, Treasurer &
SVP
Renee D. Gala
Corporate headquarters
George Town, George Town

Forecasts